Moreover, the mTORC1 and PPAR signaling pathways, which modulated lipid metabolism and promoted anti-inflammatory phenotypes, were upregulated, while pro-inflammatory pathways such as Notch, NF-κB, and MAPK signaling were downregulated in COPD (Figure 6E). The gene discussed is NFKB1; the disease is chronic obstructive pulmonary disease.